Skip to main content
Stephanie Gaillard, MD, Oncology, Lutherville, MD

Stephanie Louise Gaillard MD

Hematologic Oncology


Assistant Professor of Medicine, Duke University School of Medicine

Join to View Full Profile
  • 10803 Falls RoadPavilion III STE 1500Lutherville, MD 21093

  • Phone+1 410-583-2970

  • Fax+1 410-583-2980

Dr. Gaillard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2006

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2009 - 2026
  • PA State Medical License
    PA State Medical License 2020 - 2022
  • NC State Medical License
    NC State Medical License 2012 - 2017
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • T Cell-Inflamed Phenotype and Increased Foxp3 Expression in Infiltrating T-cells of Mismatch-Repair Deficient Endometrial Cancers  
    Stephanie Gaillard, MD, Nature

Lectures

  • The Journey of Upfront Therapy in Ovarian Cancer 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • ASCO Updates Treatment Guidance for Newly Diagnosed, Advanced Ovarian Cancer
    ASCO Updates Treatment Guidance for Newly Diagnosed, Advanced Ovarian CancerFebruary 24th, 2025
  • Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers to Present at Asco Annual Meeting
    Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers to Present at Asco Annual MeetingMay 26th, 2023
  • Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer Foundation
    Johns Hopkins Medicine Researchers Awarded Nearly $8 Million from Break Through Cancer FoundationApril 26th, 2022
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: